Patents by Inventor Jeffrey Zidichouski

Jeffrey Zidichouski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combinations of botanical extracts for promoting cardiovascular health
    Patent number: 8895079
    Abstract: A blood lipid lowering agent that functions through a same mechanism as berberine (e.g. berberine, one or more pharmacologically acceptable salts of berberine or a mixture thereof) and a blood lipid lowering agent that functions through a different mechanism than berberine (e.g. phytosterols, phytostanols, esters thereof or mixtures thereof) act synergistically to improve blood lipid profiles, for example, lowering total cholesterol, LDL-C or nonHDL-C, and triglyceride, and increasing the ratio of HDL-C to nonHDL-C. The two may be used in combination to treat or reduce the chance of contracting cardiovascular disease, hyperlipidemia, atherosclerosis, coronary heart disease, angina, cerebrovascular disease, stroke, overweight or obesity, diabetes, insulin resistance, hyperglycemia, hypertension, arrhythmia, diseases of the central nervous system, diseases of the peripheral nervous system and/or inflammation.
    Type: Grant
    Filed: February 9, 2007
    Date of Patent: November 25, 2014
    Assignee: National Research Council of Canada
    Inventors: Yanwen Wang, Jeffrey Zidichouski
  • In Vitro Model of Focal Ischemia
    Publication number: 20110212484
    Abstract: A method of modeling in vitro focal ischemia comprising: perfusing a tissue slice in vitro with an oxygenated medium; and, applying a focal insult to a targeted portion of the tissue slice. The method is particularly useful for brain tissue.
    Type: Application
    Filed: October 19, 2009
    Publication date: September 1, 2011
    Inventors: Marc J. P. Richard, Tarek M. Saleh, Bouchaib El Bahh, Jeffrey A. Zidichouski
  • Combinations of Botanical Extracts for Promoting Cardiovascular Health
    Publication number: 20100239603
    Abstract: A blood lipid lowering agent that functions through a same mechanism as berberine (e.g. berberine, one or more pharmacologically acceptable salts of berberine or a mixture thereof) and a blood lipid lowering agent that functions through a different mechanism than berberine (e.g. phytosterols, phytostanols, esters thereof or mixtures thereof) act synergistically to improve blood lipid profiles, for example, lowering total cholesterol, LDL-C or nonHDL-C, and triglyceride, and increasing the ratio of HDL-C to nonHDL-C. The two may be used in combination to treat or reduce the chance of contracting cardiovascular disease, hyperlipidemia, atherosclerosis, coronary heart disease, angina, cerebrovascular disease, stroke, overweight or obesity, diabetes, insulin resistance, hyperglycemia, hypertension, arrhythmia, diseases of the central nervous system, diseases of the peripheral nervous system and/or inflammation.
    Type: Application
    Filed: February 9, 2007
    Publication date: September 23, 2010
    Inventors: Yanwen Wang, Jeffrey Zidichouski